Compare CQP & MDLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CQP | MDLN |
|---|---|---|
| Founded | 2003 | 1966 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil/Gas Transmission | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.8B | 31.0B |
| IPO Year | 2006 | 2025 |
| Metric | CQP | MDLN |
|---|---|---|
| Price | $65.41 | $32.69 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 7 | 23 |
| Target Price | ★ $60.43 | $50.48 |
| AVG Volume (30 Days) | 86.7K | ★ 6.4M |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | ★ 5.05% | N/A |
| EPS Growth | N/A | N/A |
| EPS | 0.07 | ★ 0.23 |
| Revenue | $10,758,000,000.00 | ★ $28,432,000,000.00 |
| Revenue This Year | $6.35 | $10.88 |
| Revenue Next Year | $1.27 | $7.69 |
| P/E Ratio | $938.00 | ★ $139.61 |
| Revenue Growth | ★ 23.60 | 11.47 |
| 52 Week Low | $49.53 | $31.87 |
| 52 Week High | $71.25 | $50.88 |
| Indicator | CQP | MDLN |
|---|---|---|
| Relative Strength Index (RSI) | 42.19 | 35.82 |
| Support Level | $62.39 | N/A |
| Resistance Level | $66.84 | $37.39 |
| Average True Range (ATR) | 1.85 | 1.21 |
| MACD | -0.60 | -0.22 |
| Stochastic Oscillator | 6.52 | 9.05 |
Cheniere Energy Partners is a liquefied natural gas producer operating one facility in Sabine Pass, Louisiana. It generates most of its revenue through long-term contracts with customers on a fixed- and variable-fee payout structure. It also generates revenue by selling uncontracted LNG to customers on a short or one-time basis. The profit generated through those activities is split with parent and operator Cheniere Energy.
Medline is the largest provider of medical-surgical products and supply chain solutions in the US. The company generates over 90% of its revenue domestically and serves some of the largest US health systems. Medline offers approximately 190,000 Medline-branded products across more than 250 product families—including front-line care, surgical solutions, and laboratory and diagnostics—as well as roughly 150,000 third-party products sourced from over 1,250 vendors. The company maintains prime vendor relationships with many customers, acting as the primary consolidated logistics partner for their medical-surgical needs. Medline has significant scale, supported by more than 30 manufacturing facilities and a fleet of over 2,000 owned delivery trucks. Medline went public in December 2025.